Healthy Exercise for Lymphoma Patients (HELP)
HELP
Randomized Controlled Trial of Exercise in Lymphoma Patients
1 other identifier
interventional
122
1 country
1
Brief Summary
Objectives: The primary objective of this trial is to determine the effect of aerobic exercise training (AET) on change in quality of life (QoL) in lymphoma survivors receiving and not receiving chemotherapy. Secondary objectives are to determine the effects of AET on changes in psychosocial outcomes, cardiopulmonary fitness, body composition, and treatment completion rates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 lymphoma
Started Apr 2005
Shorter than P25 for phase_3 lymphoma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
May 26, 2005
CompletedFirst Posted
Study publicly available on registry
May 27, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2009
CompletedAugust 26, 2008
August 1, 2008
3.3 years
May 26, 2005
August 22, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in QoL between baseline and postintervention.
12 weeks
Secondary Outcomes (4)
Changes in cardiopulmonary fitness
12 weeks
psychosocial outcomes
12 weeks
body composition
12 weeks
treatment completion rates
12 weeks
Study Arms (2)
Exercise
EXPERIMENTALAerobic Exercise Training
Usual Care
NO INTERVENTIONInterventions
The exercise group will perform supervised stationary cycle ergometer exercise 3 days/week for 12 weeks and be progressed from 15 to 45 minutes and 60% to 80% of their VO2 reserve over the course of the intervention.
Eligibility Criteria
You may qualify if:
- Non-hodgkin's lymphoma (including chronic lymphocytic leukemia) or Hodgkin's disease
- Approval of the treating oncologist
- Scheduled to receive no chemotherapy or chemotherapy for at least 8 weeks
- Able to understand and provide written informed consent in English
- + years of age
- No uncontrolled hypertension, cardiac illness, psychiatric condition
- No contraindication to exercise as determined by a fitness test
You may not qualify if:
- Pregnant.
- Transplant candidate.
- Unwilling to accept randomization.
- Any medical condition that would be a contraindication to exercise. The clinicians will make this decision.
- Unwilling to travel to/participate in the exercise program as defined by the protocol.
- Planned/known absence of greater than 2 weeks during the intended study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alberta
Edmonton, Alberta, T6G2H9, Canada
Related Publications (3)
Courneya KS, Forbes CC, Trinh L, Sellar CM, Friedenreich CM, Reiman T. Patient satisfaction with participation in a randomized exercise trial: effects of randomization and a usual care posttrial exercise program. Clin Trials. 2013;10(6):959-66. doi: 10.1177/1740774513495985. Epub 2013 Aug 5.
PMID: 23918843DERIVEDCourneya KS, Sellar CM, Trinh L, Forbes CC, Stevinson C, McNeely ML, Peddle-McIntyre CJ, Friedenreich CM, Reiman T. A randomized trial of aerobic exercise and sleep quality in lymphoma patients receiving chemotherapy or no treatments. Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):887-94. doi: 10.1158/1055-9965.EPI-12-0075. Epub 2012 Apr 20.
PMID: 22523181DERIVEDCourneya KS, Stevinson C, McNeely ML, Sellar CM, Friedenreich CM, Peddle-McIntyre CJ, Chua N, Reiman T. Effects of supervised exercise on motivational outcomes and longer-term behavior. Med Sci Sports Exerc. 2012 Mar;44(3):542-9. doi: 10.1249/MSS.0b013e3182301e06.
PMID: 21814149DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kerry S Courneya, Ph.D.
University of Alberta
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 26, 2005
First Posted
May 27, 2005
Study Start
April 1, 2005
Primary Completion
August 1, 2008
Study Completion
April 1, 2009
Last Updated
August 26, 2008
Record last verified: 2008-08